한국다케다 항암제사업부에 이선진 총괄 선임

개인 기업 서치펌

인재동향

헬스케어 업계

제약/의료기기/바이오 인재동향

한국다케다 항암제사업부에 이선진 총괄 선임

작성자: 정현효

조회: 322 등록일: 2022-06-24

<p> </p><header class="article-view-header" style="box-sizing: inherit; padding: 3.125rem 0px 0px; margin: 0px auto; border-bottom: none; width: 960px; color: rgb(34, 34, 34); font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);"><h3 class="heading" style="box-sizing: inherit; margin: 0px 0px 1.375rem; padding: 0px; font-weight: bolder; color: inherit; text-rendering: optimizelegibility; font-size: 3.125rem; line-height: 1.2; letter-spacing: -0.1em;">한국다케다 항암제사업부에 이선진 총괄 선임</h3><h4 class="subheading" style="box-sizing: inherit; margin: 0px 0px 1.25rem; padding: 0px; font-weight: 300; color: inherit; text-rendering: optimizelegibility; line-height: 1.3; font-size: 1.5625rem; letter-spacing: -0.075em; border-left: none; word-break: normal; overflow-wrap: break-word;">말레이시아ㆍ싱가포르 사장 승진한 김정헌 전 총괄 후임</h4><div class="info-group" style="box-sizing: inherit; margin: 0px; padding: 1rem 0px; font-size: 0px; border-color: rgb(34, 34, 34); border-width: 7px 0px 1px; border-style: solid;"><article class="item" style="box-sizing: inherit; display: inline-block; vertical-align: middle; width: 319.99px;"><nav role="navigation" style="box-sizing: inherit;"><h3 class="show-for-sr" style="box-sizing: inherit; margin: 0px 0px 0.5rem; padding: 0px; font-weight: 400; color: inherit; text-rendering: optimizelegibility; font-size: 1.9375rem; line-height: 1.4; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">현재위치</h3><ul class="breadcrumbs" style="box-sizing: inherit; margin: 0px; padding: 0px; list-style: none; line-height: 1.6;"><li style="box-sizing: inherit; margin: 0px; padding: 0px; font-size: 0.875rem; float: left; color: rgb(10, 10, 10); cursor: default; text-transform: uppercase; line-height: 1; letter-spacing: -0.025em;"><a href="http://www.pharmnews.com/" style="box-sizing: inherit; background-color: transparent; line-height: inherit; color: rgb(85, 85, 85); text-decoration-line: none; cursor: pointer;"><i class="icon-home" style="box-sizing: inherit; line-height: inherit;"></i> 홈</a></li><li style="box-sizing: inherit; margin: 0px; padding: 0px; font-size: 0.875rem; float: left; color: rgb(10, 10, 10); cursor: default; text-transform: uppercase; line-height: 1; letter-spacing: -0.025em;"><a href="https://www.pharmnews.com/news/articleList.html?sc_section_code=S1N43&view_type=sm" style="box-sizing: inherit; background-color: transparent; line-height: inherit; color: rgb(85, 85, 85); text-decoration-line: none; cursor: pointer;">의약계소식</a></li><li style="box-sizing: inherit; margin: 0px; padding: 0px; font-size: 0.875rem; float: left; color: rgb(10, 10, 10); cursor: default; text-transform: uppercase; line-height: 1; letter-spacing: -0.025em;"><a href="https://www.pharmnews.com/news/articleList.html?sc_sub_section_code=S2N118&view_type=sm" style="box-sizing: inherit; background-color: transparent; line-height: inherit; color: rgb(85, 85, 85); text-decoration-line: none; cursor: pointer;">인사</a></li></ul></nav></article> <article class="item" style="box-sizing: inherit; display: inline-block; vertical-align: middle; width: 319.99px;"><ul class="quick-toolkit2" style="box-sizing: inherit; margin: 0px; padding: 0px; list-style: none; line-height: 1.6; display: flex; flex-wrap: wrap; justify-content: center; text-align: center;"><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool" title="인쇄" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.85rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s;"><i class="icon-print" style="box-sizing: inherit; line-height: inherit;"><span class="show-for-sr" style="box-sizing: inherit; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">바로가기</span></i></button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool sns_clipboard" data-clipboard-text="http://www.pharmnews.com/news/articleView.html?idxno=205768" title="URL주소" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.7125rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s; font-weight: 700;">URL</button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool" title="다른 공유" data-open="article-sns" aria-controls="article-sns" aria-haspopup="true" tabindex="0" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.85rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s;"><i class="icon-share-alt-o" style="box-sizing: inherit; line-height: inherit;"><span class="show-for-sr" style="box-sizing: inherit; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">다른 공유 찾기</span></i></button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool scrap-btn" data-idxno="205768" title="기사스크랩" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.85rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s;"><i class="icon-bookmark-o" style="box-sizing: inherit; line-height: inherit;"><span class="show-for-sr" style="box-sizing: inherit; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">기사스크랩하기</span></i></button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool fontsise-btn" value="down" title="본문글씨 줄이기" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.8375rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s; font-weight: 700;">가<i class="icon-minus-min" style="box-sizing: inherit; line-height: inherit;"></i></button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool fontsise-btn" value="up" title="본문글씨 키우기" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.8375rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s; font-weight: 700;">가<i class="icon-plus-min" style="box-sizing: inherit; line-height: inherit;"></i></button></li></ul></article> <article class="item" style="box-sizing: inherit; display: inline-block; vertical-align: middle; text-align: right; width: 319.99px;"><ul class="infomation" style="box-sizing: inherit; margin: 0px; padding: 0px; list-style: none; line-height: 1.6;"><li style="box-sizing: inherit; margin: 0px; padding: 0px; font-size: 0.813rem; display: inline-block; line-height: 1.125; letter-spacing: -0.05em; color: rgb(112, 112, 112); vertical-align: middle;">입력 2022.06.20 10:46</li> <li style="box-sizing: inherit; margin: 0px 0px 0px 1.5rem; padding: 0px; font-size: 0.813rem; display: inline-block; line-height: 1.125; letter-spacing: -0.05em; color: rgb(112, 112, 112); vertical-align: middle;">수정 2022.06.20 15:44</li> <li style="box-sizing: inherit; margin: 0px 0px 0px 1.5rem; padding: 0px; font-size: 0.813rem; display: inline-block; line-height: 1.125; letter-spacing: -0.05em; color: rgb(112, 112, 112); vertical-align: middle;"><span class="show-for-sr" style="box-sizing: inherit; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">기자명</span>김민건 기자</li></ul></article></div></header><section id="articleViewCon" class="article-view-content" style="box-sizing: inherit; display: flex; flex-wrap: wrap; color: rgb(34, 34, 34); font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);"><article class="grid body" style="box-sizing: inherit; flex-basis: 0px; flex-grow: 1; width: auto; max-width: 750px; min-width: 0px; margin: 0px auto; padding: 3.125rem 0px;"><div class="clearfix" style="box-sizing: inherit; margin: 0px; padding: 0px;"></div><article id="article-view-content-div" class="article-veiw-body view-page font-size17" itemprop="articleBody" style="box-sizing: inherit; font-size: 1.063rem; letter-spacing: -0.05em;"><div style="box-sizing: inherit; margin: 0px; padding: 0px; text-align: center;"><figure class="photo-layout image photo_75734 float-center" data-idxno="75734" data-type="photo" style="box-sizing: inherit; display: inline-block; margin: 0px auto 1rem; max-width: 354px; float: none !important;"><img alt="이선진 한국다케다 항암제사업부 총괄" height="333" src="https://cdn.pharmnews.com/news/photo/202206/205768_75734_4521.jpg" width="250" style="box-sizing: inherit; border-style: none; display: inline-block; vertical-align: middle; max-width: 100%; height: auto;"><figcaption style="box-sizing: inherit; padding: 0.7rem 0px; font-size: 0.8rem; line-height: 1.6em; letter-spacing: -0.05em; color: rgb(145, 145, 145); text-align: left;">이선진 한국다케다 항암제사업부 총괄</figcaption></figure></div><p style="box-sizing: inherit; margin-top: 1.25em; margin-bottom: 1em; font-size: inherit; line-height: 1.8; text-rendering: optimizelegibility; color: rgb(60, 62, 64); text-align: justify; word-break: normal; overflow-wrap: break-word;">[팜뉴스=김민건 기자] 한국다케다제약(대표 문희석)은 20일 항암제사업부(Oncology BU) 총괄에 이선진 매니저를 승진 발령했다고 밝혔다.</p><p style="box-sizing: inherit; margin-bottom: 1em; font-size: inherit; line-height: 1.8; text-rendering: optimizelegibility; color: rgb(60, 62, 64); text-align: justify; word-break: normal; overflow-wrap: break-word;">이 신임 총괄은 지난 2017년 한국다케다제약 혈우병사업부 마케팅 매니저로 입사해 마케팅 전략 개발을 담당했다. 한국다케다는 "혈우병사업 접근과 인식을 향상에 중추 역할을 수행하는 등 뛰어난 리더십 역량을 발휘했다"고 설명했다.</p><p style="box-sizing: inherit; margin-bottom: 1em; font-size: inherit; line-height: 1.8; text-rendering: optimizelegibility; color: rgb(60, 62, 64); text-align: justify; word-break: normal; overflow-wrap: break-word;">이 총괄은 아시아태평양(APAC)의 론치 앤 디지털 엑설런스 리드(Launch & Digital Excellence Lead)로서 제품 론칭을 선도했다. APAC 소속 국가들의 디지털 트랜스포메이션 실행을 위한 비전과 방향을 제시하는 등 프로젝트를 수행했다.</p><p style="box-sizing: inherit; margin-bottom: 1em; font-size: inherit; line-height: 1.8; text-rendering: optimizelegibility; color: rgb(60, 62, 64); text-align: justify; word-break: normal; overflow-wrap: break-word;">이번 승진·인사 발령은 다케다 내부에서 글로벌 네트워크 형성 기회를 제공하는 ‘FLP(Future Leaders Program)’라 대표 프로그램을 통해 이뤄졌다. 다케다제약은 특별한 직원 경험(Exceptional People Experience)이라는 가치 아래 다양한 임직원 경험과 역량 발전을 도모하고 있다. 이중 핵심인재를 선정해 특화된 프로그램을 제공하고 있다.</p><p style="box-sizing: inherit; margin-bottom: 1em; font-size: inherit; line-height: 1.8; text-rendering: optimizelegibility; color: rgb(60, 62, 64); text-align: justify; word-break: normal; overflow-wrap: break-word;">한편, 항암제사업부를 맡았던 김정헌 전 총괄은 다케다제약 FLP(Future Leaders Program)를 통해 지난 5월 말레이시아·싱가포르 사장(Country Manager)에 임명됐다.</p><p style="box-sizing: inherit; margin-bottom: 1em; font-size: inherit; line-height: 1.8; text-rendering: optimizelegibility; color: rgb(60, 62, 64); text-align: justify; word-break: normal; overflow-wrap: break-word;">김정헌 전 총괄은 2015년 마케팅 매니저로 한국다케다에 입사, 염증성장질환과 혈액암사업부를 구축했다. 2019년 항암제사업부 총괄로 임명돼 항암 제품군을 론칭했다. 3년 연속 목표를 초과 달성했다고 한국다케다는 밝혔다.</p></article></article></section><p><span style="color: rgb(60, 62, 64); font-size: inherit; text-align: justify; letter-spacing: -0.05em; background-color: rgb(255, 255, 255); font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif;">문희석 한국다케다 대표는 “이번 승진 인사 발령은 다케다의 인재 양성 프로그램을 통해 이뤄진 결과라는 점에서 더욱 의미가 있다”고 말했다.</span></p><p> </p>									<style type='text/css'> p { line-height:270%;}</style>



이전글	베이진코리아 양지혜 대표
다음글	SK바사, 의∙약학 전문 메디컬 조직 구축...김혜영 MD 영입

번호	제목	작성자	조회	등록일

284	한국유나이티드제약 임원 정기 승진 인사	정현효	183	2023-04-10

283	[인사]일동제약그룹 승진 발령	정현효	205	2023-04-05

282	인사]하나제약 전호성 상무 등 승진	정현효	200	2023-04-05

281	환인제약 이동수 전무, 부사장 승진	정현효	200	2023-04-05

280	한미약품 신임 대표 박재현 부사장…우종수...	정현효	210	2023-04-03

279	유유제약, 박노용 신임 대표 선임… 각자대...	정현효	272	2023-03-06

278	신신제약, 임직원 승진 인사(2023/1/1)	정현효	251	2023-01-26

277	보령·보령컨슈머헬스 임원 승진·보임 인...	정현효	204	2023-01-26

276	종근당 및 계열사 승진인사(2023/1/1)	정현효	231	2023-01-26

275	한국로슈, 고객 파트너십&전략 총괄에 김주...	정현효	251	2023-01-10

274	안국약품 임원 승진 인사(2023/1/1)	정현효	200	2023-01-06

273	국제약품 승진 인사(2023/1/1)	정현효	231	2023-01-06

272	삼일제약은 2023년 1월 1일부로 임원급 인...	정현효	317	2023-01-01

271	삼진제약, 임직원 승진 인사(2023년 1/1)	정현효	224	2022-12-22

270	한국의약연, 손은경 전 서울CRO 임상총괄 ...	정현효	259	2022-12-21

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10